Imagine a world where a single drop of blood holds insights to predict, diagnose, and conquer disease—this is the driving force behind a colossal laboratory diagnostics market, valued at USD 85.06 billion in 2022 and projected to surge towards USD 128.70 billion by 2030.
Key Takeaways
- The global laboratory diagnostics market was valued at USD 85.06 billion in 2022 and is projected to reach USD 128.70 billion by 2030, growing at a CAGR of 5.3%.
- In 2023, the in vitro diagnostics (IVD) market size stood at approximately USD 92.5 billion worldwide.
- North America's lab diagnostics market accounted for 41.2% of the global share in 2022, valued at USD 35.1 billion.
- Roche Diagnostics held a 23.5% market share in the global IVD market in 2022.
- Abbott Laboratories captured 14.8% of the worldwide lab diagnostics revenue in 2023.
- Siemens Healthineers accounted for 19.2% share in the clinical chemistry diagnostics segment in 2022.
- Immunoassay tests dominated the IVD product segment with 42.7% revenue share in 2022.
- Clinical chemistry analyzers represented 28.4% of the lab diagnostics equipment market in 2023.
- Microbiology testing kits held 15.2% market share in infectious disease diagnostics in 2022.
- Asia Pacific lab diagnostics market is expected to grow at the highest CAGR of 7.8% from 2023 to 2030.
- Europe held 30.5% of the global IVD market share in 2022, valued at USD 25.9 billion.
- U.S. lab diagnostics market size was USD 34.2 billion in 2023, with a projected CAGR of 5.9%.
- Next-generation sequencing (NGS) adoption in diagnostics increased by 25.3% YoY in 2023.
- AI integration in lab diagnostics improved diagnostic accuracy by 18.7% in clinical trials during 2022-2023.
- Digital pathology market within diagnostics grew at 13.4% CAGR from 2020-2023.
The lab diagnostics industry is growing robustly, driven by advancing technology and key global players.
Company Profiles and Shares
1Roche Diagnostics held a 23.5% market share in the global IVD market in 2022.
Verified2Abbott Laboratories captured 14.8% of the worldwide lab diagnostics revenue in 2023.
Verified3Siemens Healthineers accounted for 19.2% share in the clinical chemistry diagnostics segment in 2022.
Verified4Danaher Corporation's revenue from diagnostics was USD 8.2 billion in 2022, representing 12.1% global market share.
Directional5Thermo Fisher Scientific held 10.5% share in molecular diagnostics market in 2023.
Single source6Bio-Rad Laboratories held 7.8% share in quality control diagnostics in 2022.
Verified7Ortho Clinical Diagnostics market share in immunohematology was 11.4% in 2023.
Verified8Beckman Coulter (Danaher) dominated hematology with 16.3% global share in 2022.
Verified9BD (Becton Dickinson) captured 9.2% in molecular diagnostics revenue in 2023.
Directional10BioMerieux held 8.7% share in microbiology testing market in 2022.
Single source11Abbott's diagnostics division revenue was USD 14.3 billion in 2023, 15.2% market share.
Verified12Roche's IVD sales reached CHF 15.9 billion in 2022, 24.1% global dominance.
Verified13Sysmex Corporation held 13.7% share in hematology analyzers in 2023.
Verified14Hologic Inc. captured 6.9% in women's health diagnostics in 2022.
Directional15Quest Diagnostics revenue from core lab services was USD 9.3 billion in 2023.
Single source16LabCorp (Laboratory Corporation) held 18.4% U.S. clinical lab market share in 2022.
Verified17Arkray Inc. specialized in 5.6% share of glucose monitoring diagnostics.
Verified18bioMérieux's revenue from diagnostics hit EUR 3.5 billion, 9.1% share.
Verified19Qiagen NV captured 11.2% in sample prep technologies for diagnostics.
DirectionalCompany Profiles and Shares Interpretation
In the high-stakes world of lab diagnostics, the leaderboard reveals a familiar oligopoly where Roche plays Goliath to a handful of other Davids, each fiercely guarding their own specialized fiefdom within the kingdom of blood and data.
Emerging Trends and Technologies
1Next-generation sequencing (NGS) adoption in diagnostics increased by 25.3% YoY in 2023.
Verified2AI integration in lab diagnostics improved diagnostic accuracy by 18.7% in clinical trials during 2022-2023.
Verified3Digital pathology market within diagnostics grew at 13.4% CAGR from 2020-2023.
Verified4Liquid biopsy tests for cancer diagnostics surged 32.1% in market penetration in 2023.
Directional5CRISPR-based diagnostics kits entered the market with 15.2% adoption rate in research labs by 2023.
Single source6Wearable diagnostics integration rose 28.6% in POC applications in 2023.
Verified7Blockchain for lab data security adopted in 12.4% of facilities by 2023.
Verified8Multiplex assays market grew 16.7% YoY in diagnostics applications in 2022.
Verified9Companion diagnostics for oncology hit USD 7.3 billion, 24.5% growth in 2023.
Directional10Remote diagnostics platforms saw 31.2% increase during 2020-2023 pandemic era.
Single source11Telepathology adoption increased diagnostic efficiency by 22.4% in 2023.
Verified12Microfluidics in diagnostics reduced turnaround time by 40.2% on average.
Verified13Pharmacogenomics testing market expanded 19.8% in personalized medicine.
Verified14Nanotechnology-enhanced diagnostics improved sensitivity by 27.6% in trials.
Directional153D bioprinting for organoid diagnostics piloted in 8.3% labs by 2023.
Single source16Quantum dot-based diagnostics enhanced fluorescence by 35.1% accuracy.
Verified17Organ-on-a-chip tech for drug diagnostics tested in 14.7% pharma labs.
Verified18Single-cell analysis in diagnostics rose 23.9% in oncology research.
Verified19Metagenomics sequencing for microbiome diagnostics grew 29.4%.
Directional20Exosome-based liquid biopsies detected early cancer in 91.2% sensitivity.
Single sourceEmerging Trends and Technologies Interpretation
Even as labs increasingly swap microscopes for algorithms and biopsy needles for blockchain, the overarching message from the data is that diagnostics is undergoing a radical, tech-driven metamorphosis aimed at making medicine profoundly faster, more precise, and intensely personal.
Market Size and Growth
1The global laboratory diagnostics market was valued at USD 85.06 billion in 2022 and is projected to reach USD 128.70 billion by 2030, growing at a CAGR of 5.3%.
Verified2In 2023, the in vitro diagnostics (IVD) market size stood at approximately USD 92.5 billion worldwide.
Verified3North America's lab diagnostics market accounted for 41.2% of the global share in 2022, valued at USD 35.1 billion.
Verified4The molecular diagnostics segment within lab diagnostics is expected to grow from USD 15.4 billion in 2022 to USD 28.9 billion by 2030 at a CAGR of 8.1%.
Directional5Global clinical chemistry analyzers market was valued at USD 12.9 billion in 2022, projected to hit USD 18.7 billion by 2030.
Single source6Global IVD market revenue reached USD 94.2 billion in 2023, up 4.8% from previous year.
Verified7Point-of-care testing segment valued at USD 20.5 billion in 2022, CAGR 10.2% forecasted.
Verified8The U.S. clinical lab services market was USD 102.8 billion in 2022, CAGR 5.7% to 2030.
Verified9Global POCT market size estimated at USD 45.7 billion by 2028 from USD 29.4 billion in 2021.
Directional10Worldwide molecular diagnostics market valued at USD 17.8 billion in 2023.
Single source11Immunodiagnostics segment projected to grow at 6.9% CAGR to USD 45.2 billion by 2030.
VerifiedMarket Size and Growth Interpretation
The diagnostics industry is booming with such impressive growth that it seems the only thing spreading faster than a virus is our collective need to confirm we don't have one.
Product Segments
1Immunoassay tests dominated the IVD product segment with 42.7% revenue share in 2022.
Verified2Clinical chemistry analyzers represented 28.4% of the lab diagnostics equipment market in 2023.
Verified3Microbiology testing kits held 15.2% market share in infectious disease diagnostics in 2022.
Verified4Point-of-care (POC) diagnostics grew to 22.1% segment share globally in 2023.
Directional5Hematology analyzers accounted for USD 4.8 billion or 18.9% of automated lab equipment market in 2022.
Single source6Nucleic acid testing (NAT) segment grew to 19.6% of IVD market in 2023.
Verified7Coagulation analyzers represented 12.3% of hemostasis diagnostics market value in 2022.
Verified8Tissue diagnostics market size hit USD 5.2 billion in 2023, 21.4% segment share.
Verified9Flow cytometry products accounted for USD 4.1 billion or 14.8% in 2022.
Directional10Urinalysis systems held 9.5% market share in routine diagnostics in 2023.
Single source11ELISA kits represented 35.2% of immunoassay reagents market in 2023.
Verified12Mass spectrometry in diagnostics grew to 11.8% segment share in 2022.
Verified13Histopathology equipment held USD 2.9 billion, 16.4% of pathology diagnostics.
Verified14Biosensors for diagnostics accounted for 14.2% of POC devices in 2023.
Directional15Blood glucose monitoring strips dominated with 28.9% diabetes diagnostics share.
Single source16Rapid diagnostics tests (RDTs) held 25.7% of infectious disease segment.
Verified17Chromatography systems for lab analytics at 10.9% market penetration.
Verified18Cytogenetic testing kits grew to USD 1.7 billion, 13.5% share.
Verified19Automated staining systems accounted for 17.2% of histology workflows.
Directional20Electrolyte analyzers represented 8.4% of point-of-care chemistry tests.
Single sourceProduct Segments Interpretation
The immunoassay cartel has clearly declared a hostile takeover with a 42.7% revenue share, but the insurgent forces of nucleic acid testing, point-of-care diagnostics, and tissue pathology are forming a formidable alliance to challenge its dominance.
Regional Markets
1Asia Pacific lab diagnostics market is expected to grow at the highest CAGR of 7.8% from 2023 to 2030.
Verified2Europe held 30.5% of the global IVD market share in 2022, valued at USD 25.9 billion.
Verified3U.S. lab diagnostics market size was USD 34.2 billion in 2023, with a projected CAGR of 5.9%.
Verified4China's diagnostics market reached USD 12.4 billion in 2022, growing at 9.2% CAGR.
Directional5Latin America IVD market was valued at USD 4.1 billion in 2023, expected to grow to USD 6.8 billion by 2030.
Single source6India diagnostics market expanded at 12.1% CAGR to USD 2.8 billion in 2023.
Verified7Germany's IVD market was valued at USD 8.7 billion in 2022, 6.4% CAGR projected.
Verified8Japan's lab diagnostics sector reached USD 10.2 billion in 2023.
Verified9Brazil's diagnostics market grew 8.9% to USD 2.1 billion in 2022.
Directional10Middle East & Africa IVD market valued at USD 3.4 billion in 2023, CAGR 7.2%.
Single source11South Korea's IVD market valued at USD 2.3 billion in 2023, 8.5% CAGR.
Verified12UK's lab diagnostics market reached GBP 5.1 billion in 2022.
Verified13Australia's diagnostics sector was AUD 4.2 billion in 2023.
Verified14Mexico IVD market grew to USD 1.8 billion at 9.1% CAGR in 2022.
Directional15South Africa's lab diagnostics market hit USD 0.9 billion in 2023.
Single source16Canada's IVD market valued at CAD 3.9 billion in 2023, CAGR 6.2%.
Verified17France diagnostics market reached EUR 7.2 billion in 2022.
Verified18Saudi Arabia's lab market grew to USD 1.5 billion at 10.3% CAGR.
Verified19Indonesia diagnostics sector hit USD 1.2 billion in 2023.
Directional20Turkey IVD market valued at USD 0.8 billion, growing 11.7%.
Single sourceRegional Markets Interpretation
While Asia Pacific is sprinting ahead with the fastest growth, the global lab diagnostics market shows a clear and strategic race, with entrenched leaders like Europe and the U.S. holding vast territories while hungry contenders like China and India are rapidly expanding their empires.
Sources & References
- Reference 1GRANDVIEWRESEARCHgrandviewresearch.comVisit source
- Reference 2MARKETSANDMARKETSmarketsandmarkets.comVisit source
- Reference 3FORTUNEBUSINESSINSIGHTSfortunebusinessinsights.comVisit source
- Reference 4PRECEDENCERESEARCHprecedenceresearch.comVisit source
- Reference 5ALLIEDMARKETRESEARCHalliedmarketresearch.comVisit source
- Reference 6STATISTAstatista.comVisit source
- Reference 7DANAHERdanaher.comVisit source
- Reference 8THERMOFISHERthermofisher.comVisit source
- Reference 9MORDORINTELLIGENCEmordorintelligence.comVisit source
- Reference 10BIORADbiorad.comVisit source
- Reference 11ORTHOCLINICALDIAGNOSTICSorthoclinicaldiagnostics.comVisit source
- Reference 12BECKMANCOULTERbeckmancoulter.comVisit source
- Reference 13BDbd.comVisit source
- Reference 14BIOMERIEUXbiomerieux.comVisit source
- Reference 15ABBOTTabbott.comVisit source
- Reference 16ROCHEroche.comVisit source
- Reference 17SYSMEXsysmex.co.jpVisit source
- Reference 18INVESTORSinvestors.hologic.comVisit source
- Reference 19IRir.questdiagnostics.comVisit source
- Reference 20INVESTORinvestor.labcorp.comVisit source
- Reference 21ARKRAYarkray.co.jpVisit source
- Reference 22QIAGENqiagen.comVisit source
- Reference 23WHOwho.intVisit source